Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Finished Goods (2020 - 2021)

Journey Medical (DERM) has disclosed Finished Goods for 2 consecutive years, with $4.3 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Finished Goods rose 205.56% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Dec 2021, up 205.56%, and an annual FY2021 reading of $4.3 million, up 205.56% over the prior year.
  • Finished Goods was $4.3 million for Q4 2021 at Journey Medical, down from $6.2 million in the prior quarter.
  • Across five years, Finished Goods topped out at $6.2 million in Q3 2021 and bottomed at $1.4 million in Q4 2020.